semaglutide gut microbiome alleviates microbiota dysbiosis induced by a high-fat diet Frontiers | Effects of semaglutide

TRIUMPH-1's 11.3% represents an improvement over TRIUMPH-4's 18.2%, and suggests the general obesity population tolerates retatrutide better than the older, more comorbid OA population in TRIUMPH-4

All claims are evidence-based, emphasizing the need for medical supervision due to gastrointestinal (GI) risks, potential thyroid concerns, and contraindications like personal/family history of medullary thyroid carcinoma (MTC)

Aim for 1.0 to 1.6 grams of protein per kilogram of body weight daily

Methodology: Data from 200 patients was examined with the intention of identifying those who would be suitable candidates for weight loss treatment with a GLP-1 agonist

Plateaus are common and usually temporary